Aztreonam for Inhalation Solution (AZLI)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Aztreonam for Inhalation Solution (AZLI), covering 2016-05-09 to 2016-05-09. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy Regimen for the Treatment of Chronic Pseudomonas Aeruginosa Infection in Patients With CF [Phase 3]